Literature DB >> 17542668

Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma.

Clara Ugolini1, Fulvio Basolo, Agnese Proietti, Paolo Vitti, Rossella Elisei, Paolo Miccoli, Antonio Toniolo.   

Abstract

OBJECTIVE: Numerous studies indicate that papillary thyroid carcinomas (PTC) with lymphocytic infiltrates are associated with a less extensive disease at diagnosis and improved disease-free survival. The infiltration of lymphocytes and immature CD1a+ dendritic cells (DC) was characterized in papillary, poorly differentiated (PDC), and undifferentiated (UC) carcinomas to evaluate their association with immunological infiltrates.
DESIGN: A series of 527 consecutive cases of thyroid carcinoma treated by total thyroidectomy were investigated by histopathological and immunohistochemical methods. The inflammatory infiltrate was quantified and typed in intratumoral and peritumoral tissues as well as in the controlateral lobe. MAIN OUTCOME: The intratumoral infiltrate was strongly reduced or absent in PDC and UC. Intense infiltrates were detected in the PTC tall cell variant. In all histotypes, the extent of the intratumoral and peritumoral infiltrates was comparable. Immature DC were detected in PTCs and markedly reduced in PDC and UC. CD1a+ DCs were detected in a small percentage of PDC and UC.
CONCLUSIONS: Though a relationship between the extent of lymphocyte/DC infiltrates and the prognosis of PTCs could not be demonstrated, tumors with poor prognosis (PDCs, UCs) were characterized by markedly reduced lymphocyte/DC infiltrates. The study appears to confirm the protective role of DC and infiltrating lymphocytes against thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17542668     DOI: 10.1089/thy.2006.0306

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  29 in total

1.  The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer.

Authors:  Jin-Seong Cho; Min-Ho Park; Young-Jae Ryu; Jung-Han Yoon
Journal:  Ann Surg Treat Res       Date:  2015-03-26       Impact factor: 1.859

Review 2.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

3.  Is diffuse and peritumoral lymphocyte infiltration in papillary thyroid cancer a marker of good prognosis?

Authors:  D G P N Villagelin; R B Santos; J H Romaldini
Journal:  J Endocrinol Invest       Date:  2011-07-13       Impact factor: 4.256

4.  Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.

Authors:  Jena D French; Zachary J Weber; Deborah L Fretwell; Sherif Said; Joshua P Klopper; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2010-03-05       Impact factor: 5.958

5.  Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.

Authors:  Sunmi Park; Jack Zhu; Grégoire Altan-Bonnet; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

6.  Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.

Authors:  Andrey Bychkov; Vladimir Saenko; Masahiro Nakashima; Norisato Mitsutake; Tatiana Rogounovitch; Alyaksandr Nikitski; Florence Orim; Shunichi Yamashita
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

7.  Urinary neopterin levels in patients with thyroid cancer.

Authors:  Serap Soytac Inancli; Sedat Caner; Fevzi Balkan; Abbas Ali Tam; Gulnur Guler; Reyhan Ersoy; Bekir Cakir
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-02-18

8.  Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study.

Authors:  Francesco Cicone; Annalisa Papa; Chiara Lauri; Anna Tofani; Camilla Virili; Marco Centanni; Francesco Scopinaro; Bruno Annibale
Journal:  Endocrine       Date:  2014-09-12       Impact factor: 3.633

9.  Immunotherapy in anaplastic thyroid cancer.

Authors:  Maoguang Ma; Bo Lin; Mingdian Wang; Xiaoli Liang; Lei Su; Okenwa Okose; Weiming Lv; Jie Li
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 10.  Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment.

Authors:  Ramin Lotfi; Christof Kaltenmeier; Michael T Lotze; Christoph Bergmann
Journal:  Transfus Med Hemother       Date:  2016-03-08       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.